Seeking Alpha

bucket178

bucket178
Send Message
View as an RSS Feed
View bucket178's Comments BY TICKER:
Latest  |  Highest rated
  • Navidea Biopharmaceuticals, Inc Management Discusses Q1 2013 Results - Earnings Call Transcript [View article]
    If you want to get a lesson in double talk read Pykett's response to the question on how the launch is going. How about a short and sweet, "I am pleased to say we already have orders for Lymphoseek" The clear implication from all the doubletalk is they have no orders. No wonder the stock continues to sink.
    May 9 11:19 AM | Likes Like |Link to Comment
  • A Likely Turnaround And Short Squeeze For Navidea Shares [View article]
    The street info that Cardinal Health also markets competing product was brought up in the Q & A session, creating a possible conflict. Management gave some good reasons why they would promote Lymphoseek. The biggest reason would be more profit. Does anyone know the dollars that go to Cardinal for a unit of the competing product, compared to the $110 or so they are projected to get for Lymphoseek?
    Mar 18 05:16 PM | Likes Like |Link to Comment
  • Opportunity On The Horizon For Discovery Laboratories Investors [View article]
    Suppose 2 approved products achieve sales rate of $80MM within next 12 months. suppose shares out reach 50MM. Sales/share $1.60. If 4 x sales is going rate, shares are worth $6.40. Who needs a billion in sales? What am I missing?
    Mar 27 12:10 AM | Likes Like |Link to Comment
  • Opportunity On The Horizon For Discovery Laboratories Investors [View article]
    Suppose 2 approved products achieve sales rate of $80MM/year within the next 12 months. Suppose shares outstanding are 50MM.
    Sales/share =$1.60. If going rate is 4 x sales, stock is worth $6.40 per share. Who needs a billion in sales. What am I missing?
    Mar 27 12:10 AM | Likes Like |Link to Comment
  • Opportunity On The Horizon For Discovery Laboratories Investors [View article]
    I am not sure I understand your numbers. Suppose the two approved products achieve a combined annual sales rate of $80MM starting in the 4th quarter. Suppose, with warrants etc they get to 50MM shares outstanding. Sales/share = $1.60. If price to sales is about 4x, 4x$1.60 = $6.40/SH. Who needs a billion in sales? What am I missing?
    Mar 27 12:10 AM | Likes Like |Link to Comment
COMMENTS STATS
5 Comments
0 Likes